Chronic obstructive pulmonary disease (COPD) is a group of diseases that affect the lungs. The disease makes it difficult to breath and progressively gets worse. About 15 million Americans have been ...

COPD is a disease that damages your lungs over time. It may start with mild symptoms and then get worse. Treatment can help symptoms and slow disease progression. Chronic obstructive pulmonary disease ...

The natriuretic peptides, specifically brain natriuretic peptide (BNP), are the most specific and applicable laboratory tests available to establish fluid overload associated with HF. 9 BNP is ...

Among patients who have chronic obstructive pulmonary disease (COPD), the pathophysiology for disturbed sleep consists of physiological changes, ventilatory disturbances, and inflammation. For ...

Your lungs are vital for providing your body with fresh oxygen while ridding it of carbon dioxide. This process is called gas exchange. In some individuals, such as those with chronic obstructive ...

The reason some people who have never smoked a cigarette develop a smoking-related illness may be due to the size of their respiratory system. People who have small airways relative to their lung size ...

The FDA approved dupilumab (Dupixent) as the first biologic treatment for adults with chronic obstructive pulmonary disease (COPD), Sanofi and Regeneron announced on Friday. An injectable interleukin ...

Chronic obstructive pulmonary disease, or COPD, is among the most common lung diseases in the world. COPD is a blanket term for several progressive lung diseases such as emphysema, chronic bronchitis, ...

A retrospective analysis of patient data from the COPDGene study suggests that targeting mucus plugs could help prevent deaths from chronic obstructive pulmonary disease—the fourth leading cause of ...

Charles Burger, MD: Pulmonary hypertension really refers to a state where the right heart is generating high pressures to circulate the blood through the lung. Pulmonary arterial hypertension is a ...

Patients with COPD who travel to high altitudes have an estimated PaO2 decrease of 0.84 kPa with each 1000 meter of altitude gain. High-altitude travel in patients with chronic obstructive pulmonary ...